Page 2 - Cellular Proteomics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Altered cerebrospinal fluid proteins in the brain associated with even mild COVID-19 could serve as promising therapeutic targets to prevent further complications.

Welcome to the March 21, 2022 installment of Research Roundup , a recurring snapshot of recent studies published by scientists at the Broad Institute and their collaborators.

During the pandemic, it has become increasingly evident that people with cardiovascular disease and obesity are at a much higher risk of developing very severe, even fatal COVID-19 disease.

During the pandemic, it has become increasingly evident that people with cardiovascular disease and obesity are at a much higher risk of developing very severe, even fatal COVID-19 disease. Researchers at Karolinska Institutet in Sweden have identified some metabolic processes that SARS-CoV-2 uses to attack lung tissue. The results, which are published in Molecular & Cellular Proteomics, could one day be used to treat COVID-19, and potentially for other viruses like the Crimean-Congo hemorrhagic fever virus and HIV-1.

Illustration by Gerd Altmann/Public Domain/Pixabay. During the pandemic, it has become evident that people with cardiovascular disease and obesity are